Zylox Ton-bridge is a top player in peripheral and neurovascular interventional devices. Providing more than 40 quality revascularization products, our production line include ischemic & hemorrhagic stroke devices, vascular access products and so on.

Zylox Ton-bridge provides neurovascular embolization coiling solutions for hemorrhagic stroke and aneurysm coiling. Our catheter coil is well-known for its softness, quick and stable mechanical detachment with stability and wide offering.

Latest News What Is the Difference Between Distal Access Catheters and Intracranial Support Catheters? Feb 26, 2025 Zylox-Tonbridge 2024 Investor Open Day Successfully Held in Hangzhou Dec 04, 2024 Interpretation of the Industry for Thrombectomy Stents Nov 09, 2024

Neurointerventional Radial Access Sheath: Super-Selection Catheter + Therapeutic Catheter Hybrid braid of nitinol and stainless steel, featuring a coil structure for enhanced resistance to flattening and kinking, while maintaining excellent flexibility. SIM1.5, SIM2.5, and MP distal tip designs tailored for different aortic arches, offering personalized clinical solutions. Dual-sheath ...

Zylox Ton-bridge provides peripheral stent system for artery diseases. The unique spiral design of these peripheral artery & vascular disease stents achieves excellent flexibility and superior vascular compliance.

Zylox-Tonbridge is launching the CYLONE™ Aspiration Catheter in the global market. After introducing the Thrombite™ Clot Retriever Device last year, Zylox-Tonbridge brings again a new option for patients experiencing acute ischemic stroke and their caregivers.

Home Healthcare Professionals Products Vascular Interventions Venous ZYLOX Eagle™ Peripheral Thrombus aspiration system

The full platform of 0.014", 0.018", and 0.035" meets various peripheral surgical needs; Balloon diameters range from 1.5mm to 12mm, with additional half sizes of 4.5mm and 5.5mm, and balloon lengths from 15mm to 220mm; Upgraded ZENFLOW® balloon platform with a burst pressure of up to 18 ATM; Upgraded delivery system for improved pushability.

VOLUNTARY ANNOUNCEMENT NATIONAL MEDICAL PRODUCTS ADMINISTRATION GRANTED MARKETING APPROVAL FOR ZYLOX® PHOENIX PERIPHERAL DETACHABLE FIBROUS COIL EMBOLIZATION SYSTEM

On July 12, 2021, ZYLOX-TONBRIDGE (2190.HK) announced that the Company has successfully completed enrollment in the PEVENSEY study. The PEVENSEY study is a prospective multicenter randomized controlled clinical trial designed to gain the China National Medical Products Administration (NMPA) approval for its Zynlastic™ peripheral venous stent ...